Progyny Partners with ŌURA to Empower Women and Their Care Teams with Wearable Tech Data, Further Supporting Outcomes from Preconception to Menopause
Progyny (Nasdaq: PGNY) has announced a strategic partnership with ŌURA, a leading smart ring manufacturer, to enhance women's health monitoring and care from preconception through menopause. The collaboration will integrate ŌURA's wearable technology data into Progyny's healthcare ecosystem starting in early 2026.
The partnership aims to provide comprehensive health tracking capabilities, including sleep patterns, cycle insights, cardiovascular health, and stress levels. This data integration will enable earlier risk identification and support various health goals, particularly in fertility planning and menopause management. The initiative will be available to Progyny's client base, including employers and health plans.
Progyny (Nasdaq: PGNY) ha annunciato una partnership strategica con ŌURA, un'azienda leader nella produzione di anelli intelligenti, per migliorare il monitoraggio e la cura della salute femminile dalla fase preconcezionale fino alla menopausa. La collaborazione integrerà i dati della tecnologia indossabile di ŌURA nell'ecosistema sanitario di Progyny a partire da inizio 2026.
L'accordo mira a offrire funzionalità complete di monitoraggio della salute, includendo i modelli del sonno, le informazioni sul ciclo, la salute cardiovascolare e i livelli di stress. Questa integrazione dei dati consentirà un'identificazione precoce dei rischi e supporterà vari obiettivi di salute, in particolare nella pianificazione della fertilità e nella gestione della menopausa. L'iniziativa sarà disponibile per la clientela di Progyny, compresi datori di lavoro e piani sanitari.
Progyny (Nasdaq: PGNY) ha anunciado una alianza estratégica con ŌURA, un fabricante líder de anillos inteligentes, para mejorar el monitoreo y cuidado de la salud femenina desde la preconcepción hasta la menopausia. La colaboración integrará los datos de la tecnología wearable de ŌURA en el ecosistema de salud de Progyny a partir de principios de 2026.
La asociación busca ofrecer capacidades completas de seguimiento de la salud, incluyendo patrones de sueño, información del ciclo, salud cardiovascular y niveles de estrés. Esta integración de datos permitirá una identificación temprana de riesgos y apoyará diversos objetivos de salud, especialmente en la planificación de la fertilidad y el manejo de la menopausia. La iniciativa estará disponible para la base de clientes de Progyny, incluidos empleadores y planes de salud.
Progyny (나스닥: PGNY)는 여성 건강 모니터링과 관리를 임신 전부터 폐경기까지 향상시키기 위해 스마트 링 선도 제조업체인 ŌURA와 전략적 파트너십을 발표했습니다. 이 협력은 2026년 초부터 ŌURA의 웨어러블 기술 데이터를 Progyny의 헬스케어 생태계에 통합할 예정입니다.
이번 파트너십은 수면 패턴, 생리 주기 정보, 심혈관 건강, 스트레스 수준 등 포괄적인 건강 추적 기능을 제공하는 것을 목표로 합니다. 데이터 통합을 통해 조기 위험 인식이 가능하며, 특히 임신 계획과 폐경 관리에 있어 다양한 건강 목표를 지원합니다. 이 이니셔티브는 Progyny의 고객층인 고용주 및 건강 보험 플랜에 제공될 예정입니다.
Progyny (Nasdaq : PGNY) a annoncé un partenariat stratégique avec ŌURA, un fabricant leader de bagues intelligentes, afin d'améliorer la surveillance et les soins de la santé des femmes, de la préconception à la ménopause. Cette collaboration intégrera les données de la technologie portable d'ŌURA dans l'écosystème de santé de Progyny à partir du début 2026.
Le partenariat vise à offrir des capacités complètes de suivi de la santé, incluant les cycles de sommeil, les informations sur le cycle menstruel, la santé cardiovasculaire et les niveaux de stress. Cette intégration des données permettra une identification précoce des risques et soutiendra divers objectifs de santé, notamment dans la planification de la fertilité et la gestion de la ménopause. L'initiative sera accessible à la clientèle de Progyny, comprenant employeurs et régimes d'assurance santé.
Progyny (Nasdaq: PGNY) hat eine strategische Partnerschaft mit ŌURA, einem führenden Hersteller von Smart-Ringen, angekündigt, um die Gesundheitsüberwachung und -versorgung von Frauen von der Empfängnisvorbereitung bis zur Menopause zu verbessern. Die Zusammenarbeit wird ab Anfang 2026 die Daten der Wearable-Technologie von ŌURA in das Gesundheitsökosystem von Progyny integrieren.
Das Ziel der Partnerschaft ist es, umfassende Gesundheitsüberwachungsfunktionen bereitzustellen, darunter Schlafmuster, Zyklusinformationen, Herz-Kreislauf-Gesundheit und Stresslevel. Diese Datenintegration ermöglicht eine frühere Risikoerkennung und unterstützt verschiedene Gesundheitsziele, insbesondere bei der Familienplanung und dem Management der Menopause. Die Initiative wird Progynys Kundenbasis, einschließlich Arbeitgebern und Gesundheitsplänen, zur Verfügung stehen.
- Integration of advanced wearable technology enhances Progyny's healthcare monitoring capabilities
- Expansion of services to cover broader women's health spectrum from preconception to menopause
- Early risk identification potential through continuous health monitoring
- Enhanced data-driven decision support for healthcare providers
- Implementation not starting until early 2026, indicating a lengthy rollout timeline
Insights
Progyny's partnership with ŌURA integrates wearable health data into women's healthcare, potentially enhancing treatment outcomes and expanding service offerings.
Progyny's new partnership with ŌURA represents a strategic expansion of its digital health capabilities in the women's health and family building space. By incorporating ŌURA's wearable technology data into their care model, Progyny is moving toward a more proactive, data-driven approach to reproductive healthcare that extends from preconception through menopause.
The integration of continuous health metrics including sleep patterns, cycle insights, and stress levels provides Progyny with valuable physiological data points that were previously unavailable between clinical visits. This creates opportunities for earlier risk identification and more personalized interventions, potentially improving clinical outcomes while expanding Progyny's value proposition to clients.
For Progyny's business model, this partnership introduces a new revenue stream through ŌURA device and membership distribution beginning in early 2026. The company is effectively broadening its service offerings beyond fertility benefits management into more comprehensive women's health monitoring and support. This move aligns with healthcare's shift toward preventative, continuous care models rather than episodic treatment approaches.
The timing is particularly strategic as employers and health plans increasingly seek comprehensive solutions that address the full spectrum of women's health needs. By extending its reach into daily health monitoring and management, Progyny positions itself as a more holistic provider in the competitive fertility and women's health benefits space, potentially increasing client retention and expanding market share.
NEW YORK, July 10, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, today announced a new partnership with ŌURA, maker of the world’s leading smart ring, further empowering women to better understand and take action on their health through comprehensive data and personalized insights.
By incorporating wearable data and insights from ŌURA into the care team decision-support process—from preconception to menopause—Progyny is engaging members upstream as they are being more proactive with their health. As a result, potential risks can be identified earlier, while also supporting a range of health goals, such as optimizing conception attempts or making sustainable lifestyle changes.
“The more women understand about their bodies, the more empowered they are to partner with their health providers and articulate their health status and goals. Whether you are focused on conceiving your first child or managing changing weight and sleep issues through menopause, understanding your personal data is powerful—physically and emotionally,” said Janet Choi, MD, Progyny Chief Medical Officer. “Taking control with physiologic data from the Oura Ring further supports Progyny’s focus on raising the bar and elevating health outcomes.”
With the ability to continuously track key health metrics, such as sleep patterns, cycle insights, cardiovascular health, stress levels, and more, ŌURA helps women understand their bodies so they can achieve optimal health. For those trying to conceive, these insights can help pinpoint fertile windows and support reproductive planning. During perimenopause or menopause, they can help identify patterns, guide impactful lifestyle adjustments, and inform meaningful conversations with providers. When needed, care plans, including personalized recommendations around sleep, nutrition, movement, and stress to support the body’s changing needs can be developed.
“Reproductive health management starts long before a doctor's visit—it begins with daily awareness of your body's patterns,” said Dorothy Kilroy, Chief Commercial Officer at ŌURA. “By partnering with Progyny, we’re bridging the gap between those daily health patterns and clinical care, helping people navigate fertility and family planning with greater clarity, confidence, and support. This collaboration brings Oura’s powerful health signals into a setting where they can truly make a difference—guiding smarter care, earlier interventions, and more personalized journeys.”
Oura Ring and Oura Membership will be available to Progyny clients, including employers and health plans, beginning in early 2026.
About Progyny
Progyny (Nasdaq: PGNY) is a global leader in women’s health and family building solutions, trusted by the nation’s leading employers, health plans and benefit purchasers. We envision a world where everyone can realize their dreams of family and ideal health. Our outcomes prove that comprehensive, inclusive, and intentionally designed solutions simultaneously benefit employers, patients, and physicians.
Our benefits solution empowers patients with concierge support, coaching, education, and digital tools; provides access to a premier network of fertility and women's health specialists who use the latest science and technologies; drives optimal clinical outcomes; and reduces healthcare costs.
Headquartered in New York City, Progyny has been recognized for its leadership and growth as a TIME100 Most Influential Company, CNBC Disruptor 50, Modern Healthcare's Best Places to Work in Healthcare, Forbes' Best Employers, Financial Times Fastest Growing Companies, Inc. 5000, Inc. Power Partners, and Crain's Fast 50 for NYC. For more information, visit www.progyny.com.
For More Information, Please Contact:
Media:
Alexis Ford
media@progyny.com
Investors:
James Hart
investors@progyny.com
FAQ
What is the partnership between Progyny and ŌURA?
When will the Progyny-ŌURA partnership services become available?
What health metrics will the ŌURA ring track for Progyny members?
How will the Progyny-ŌURA partnership benefit women trying to conceive?
What benefits does the PGNY-ŌURA partnership offer for menopausal women?
